Skip to content

Aromatherapy and Anxiety Study

The Effect of Aromatherapy on Situational Anxiety in Adults Receiving Intra-Articular Injections in the Ambulatory Clinic Setting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05832983
Enrollment
20
Registered
2023-04-27
Start date
2023-07-04
Completion date
2024-02-21
Last updated
2025-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Related to Pain Related to an Intraarticular Injection, Pain Related to an Intraarticular Injection

Brief summary

While intra-articular injections can alleviate pain in orthopedic patients, this can be an anxiety-provoking experience. Adult patients scheduled to receive an injection at the study location will be randomly assigned to one of three groups. The control group (C) will receive the current standard of nursing care. The first experimental group (A) will receive a guided meditation prior to receiving the injection. The second experimental group (B) will receive an Elequil Aromatab and the same guided meditation prior to receiving the injection.

Detailed description

The objective of the study is to measure the difference in anxiety levels of adult orthopedic patients in need of intra-articular injections who receive a guided meditation only prior to their injection, compared to those who receive a guided meditation and an aromatherapy Elequil Aromatab prior to injection, as well as compared with those who receive the usual standard of care

Interventions

In private exam room, the study registered nurse (RN) will read a prepared two minute guided meditation to patient.

OTHERAromatherapy

In private exam room, study RN will first affix an Elequil Aromatab to patient's clothing on either their upper arm or chest (whichever the patient prefers and/or as clothing allows).

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patient has an in-office appointment at the NYU Langone Ambulatory Care-23rd Street location with either the Ortho A & B (primarily those patients who may be seeking knee or hip replacement surgery), Hand, or Primary Sport clinics. * Patient has an order for an intra-articular injection (as determined by clinic MD) and has consented to receiving that treatment. * Patient is English speaking.

Exclusion criteria

* Patient has a cognitive or physical disability that would interfere with their ability to complete the study's pre and post assessments with RN. * Patient is found on the pre-injection assessment form to have an intolerance or allergy to lavender, sandalwood, or strong scents in general.

Design outcomes

Primary

MeasureTime frameDescription
Change in Short-Version Spielberger State-Trait Anxiety Inventory (SSTAI) Score10-15 minutes prior to injection, 5 minutes post-injection (Day 1)The Short-Version SSTAI is a 10-item self-assessment of anxiety, with 5 items assessing states of anxiety and 5 items assessing traits of anxiety. Each item is scored on a Likert scale ranging from 1 to 4, where (1 = not at all) and (4 = very much so). The total score is the sum of responses and ranges from 10-40; lower scores indicate lower levels of anxiety. A decrease in scores indicates anxiety decreased during the observational period.
Change in Pain Score10-15 minutes prior to injection, 5 minutes post-injection (Day 1)On a scale of 0 to 10 (0 = no pain, 10 = the worst pain imaginable), participants rank their pain prior to the injection and after the injection. The total score ranges from 0-10, with higher scores indicating greater pain. A decrease in score indicates pain decreased during the observational period.
Change in Blood Pressure10-15 minutes prior to injection, 5 minutes post-injection (Day 1)Participants will have their blood pressure (systolic/diastolic - mmHg) taken before and after the injection.
Change in Heart Rate10-15 minutes prior to injection, 5 minutes post-injection (Day 1)Participants will have their heart rate (beats per minute) measured before and after the injection.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026